The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports

MK Ghosh, D Chakraborty, S Sarkar… - Signal transduction and …, 2019 - nature.com
Glioma and cerebral ischemic stroke are two major events that lead to patient death
worldwide. Although these conditions have different physiological incidences,~ 10% of …

Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival

C Henker, T Kriesen, Ä Glass, B Schneider… - Journal of neuro …, 2017 - Springer
The potential impact of different radiological features of glioblastoma multiforme (GBM) on
overall survival (OS) like tumor volume, peritumoral edema (PTE), necrosis volume, necrosis …

[HTML][HTML] Theranostic nanomedicine for malignant gliomas

M d'Angelo, V Castelli, E Benedetti… - … in bioengineering and …, 2019 - frontiersin.org
Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant
gliomas represent an incurable disease; indeed, after surgery and chemotherapy …

[HTML][HTML] Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide

JR Melamed, JT Morgan, SA Ioele, JP Gleghorn… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Resistance to chemotherapy substantially hinders successful glioblastoma (GBM) treatment,
contributing to an almost 100% mortality rate. Resistance to the frontline chemotherapy …

A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells

A Balbous, U Cortes, K Guilloteau, P Rivet, B Pinel… - BMC cancer, 2016 - Springer
Background Radioresistant glioblastoma stem cells (GSCs) contribute to tumor recurrence
and identification of the molecular targets involved in radioresistance mechanisms is likely to …

Tumor niches: perspectives for targeted therapies in glioblastoma

R Srivastava, M Dodda, H Zou, X Li… - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: Glioblastoma (GBM), the most common and lethal primary brain tumor with a
median survival rate of only 15 months and a 5-year survival rate of only 6.8%, remains …

Dendritic cell vaccine trials in gliomas: Untangling the lines

KM Hotchkiss, KA Batich, A Mohan, R Rahman… - Neuro …, 2023 - academic.oup.com
Glioblastoma is a deadly brain tumor without any significantly successful treatments to date.
Tumor antigen-targeted immunotherapy platforms including peptide and dendritic cell (DC) …

The great escape: the power of cancer stem cells to evade programmed cell death

V Castelli, A Giordano, E Benedetti, F Giansanti… - Cancers, 2021 - mdpi.com
Simple Summary Several current therapies fail to eradicate tumors due to the ability of
cancer stem cells (CSCs) to escape different programmed cell deaths. In fact, apoptosis …

Sensing of survivin mRNA in malignant astrocytes using graphene oxide nanocarrier-supported oligonucleotide molecular beacons

M Stobiecka, B Dworakowska, S Jakiela… - Sensors and Actuators B …, 2016 - Elsevier
While a significant progress has recently been made in therapy of many cancers, the cure for
some high grade cancers, such as the astrocytic cancers, remains elusive. In the latter case …

The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directions

R Shrivastava, P Gandhi, R Gothalwal - Clinical and Translational …, 2022 - Springer
Gliomas are primary intracranial tumors with defined molecular markers available for precise
diagnosis. The prognosis of glioma is bleak as there is an overlook of the dynamic crosstalk …